---
title: "INmune Bio wins MHRA pediatric plan approval for Ebstrocel in RDEB"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290819635.md"
description: "INmune Bio received UK MHRA approval for a Pediatric Investigation Plan for Ebstrocel in recessive dystrophic epidermolysis bullosa. This clearance supports the company's planned UK marketing authorization application in 2026 and reaffirms its goal to file for US Accelerated Approval in early 2027."
datetime: "2026-06-25T11:01:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290819635.md)
  - [en](https://longbridge.com/en/news/290819635.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290819635.md)
generator: "portal-rs"
---

# INmune Bio wins MHRA pediatric plan approval for Ebstrocel in RDEB

-   INmune Bio won UK MHRA clearance of a Pediatric Investigation Plan for Ebstrocel in recessive dystrophic epidermolysis bullosa. \* The step supports a planned UK marketing authorization application in 2026. \* The company reiterated plans for a US Accelerated Approval filing in early 2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606250700PRIMZONEFULLFEED9752311) on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [INMB.US](https://longbridge.com/en/quote/INMB.US.md)

## Related News & Research

- [INmune Bio submits EMA orphan drug application for Ebstrocel in RDEB](https://longbridge.com/en/news/297032741.md)
- [INmune Bio (NASDAQ:INMB) Stock Price Down 1.3%  - What's Next?](https://longbridge.com/en/news/297595042.md)
- [Scholar Rock says FDA grants fast track status for apitegromab in FSHD](https://longbridge.com/en/news/297781889.md)
- [CHICAGO WHITE SOX, CIBC AND LOCAL NONPROFITS UNITE FOR CHILDHOOD CANCER AWARENESS DAY ON SEPTEMBER 6 | CM Stock News](https://longbridge.com/en/news/297935859.md)
- [Ionis: FDA approves ZANVASTRO for Alexander disease, pivotal study shows 33.3% gait stabilization](https://longbridge.com/en/news/298024012.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**